Ibisobanuro
4-amino-5-methyl-2-hydroxypyridine ni intera nyamukuru hagati ya synthesis ya Finerenone, uburyo bushya butari steroidal bwatoranijwe bwa mineralocorticoid reseptor antagonist ifite ubushobozi bwo kuvura indwara zifata umutima nimiyoboro nimpyiko.Ibishoboka.Uru ruganda nigice cyingenzi mubikorwa bya Finerenone, rukaba ikintu cyingenzi mubigo bikorerwamo ibya farumasi nibigo byubushakashatsi.
Ubuziranenge nubuziranenge bwa 4-amino-5-methyl-2-hydroxypyridine ntagereranywa, byemeza ko bikwiranye ninzego zose ziterambere ryibiyobyabwenge ninganda.Hamwe no kwibanda ku kuba indashyikirwa no guhanga udushya, twahinduye uburyo bwo guhuza no kweza kugira ngo dutange ibicuruzwa byujuje ubuziranenge bw’inganda zikora imiti.
Ubwitange bwacu bufite ireme bugera kuri buri kintu cyose cyibikorwa byacu, uhereye ku bikoresho fatizo biva mu nganda no kubikwirakwiza.Twubahiriza ibipimo bihanitse byumutekano no kubahiriza kugirango abakiriya bacu bakire ibicuruzwa byujuje ibyangombwa bisabwa n'amategeko.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ry'umwuga ryizeza R&D y'ibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
